| 17.07.2024 17:32:32 | |
|---|---|
| Cena | |
| 32,635 EUR | |
| Změna | 3,11% (0,99) |
Základní údaje
| ISIN | US0718131099 |
| Symbol | BAX |
| Burza | Vienna Stock Exchange |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 16.613 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 32,585 EUR |
| Max | 32,98 EUR |
| Min | 32,50 EUR |
| Závěrečná cena (předchozí den) | 31,65 EUR |
| Cena vážená obchodovaným objemem | 32,895 EUR |
| Objem (kusy) | 319 |
| Obchodovaný objem | 10.493,53 |
| Počet obchodů | 11 |
| Poslední zobchodovaný počet | 0 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: BAXTER INTERNATIONAL INC |  |
Přidat benchmark:
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 12.07.2024 |
|
Global Equity Ratings |
|
| 21.06.2024 |
|
Global Equity Ratings |
|
| 14.06.2024 |
|
Global Equity Ratings |
|
| 29.05.2024 |
|
Global Equity Ratings |
|
| 26.04.2024 |
|
Global Equity Ratings |
|
Všechny burzy pro BAXTER INTERNATIONAL INC
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Vienna Stock Exchange | 17.07.2024 | 17:32 | 32,635 EUR | 0,01 | 11 |
| Tradegate | 17.07.2024 | 16:59 | 33,185 EUR | 0,06 | 6 |
| Stuttgart | 17.07.2024 | 21:14 | 32,59 EUR | 0,00 | 4 |
| NYSE | 17.07.2024 | 21:25 | 35,69 USD | 133,23 | 32.121 |
| Munich | 17.07.2024 | 08:01 | 32,35 EUR | 0,00 | 1 |
| London Stock Exchange | 12.12.2023 | 16:52 | 36,35 USD | 0,01 | 1 |
| Hanover | 17.07.2024 | 08:09 | 32,35 EUR | 0,00 | 1 |
| Hamburg | 17.07.2024 | 08:06 | 32,35 EUR | 0,00 | 1 |
| Frankfurt | 17.07.2024 | 15:29 | 32,195 EUR | 0,12 | 7 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0,00 | - |
| Euronext Milan MTF Global Equity Market | 17.07.2024 | 17:44 | 32,69 EUR | 0,00 | 1 |
| Duesseldorf | 17.07.2024 | 19:30 | 32,475 EUR | 0,00 | 5 |
| Berlin | 17.07.2024 | 20:30 | 32,635 EUR | 0,00 | 17 |
| 17.07.2024 17:32:32 | |
|---|---|
| Cena | |
| 32,635 EUR | |
| Změna | 3,11% (0,99) |
Základní údaje
| ISIN | US0718131099 |
| Symbol | BAX |
| Burza | Vienna Stock Exchange |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 16.613 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | - |
| Prodej (částka) | - |
| Otevírací cena | 32,585 EUR |
| Max | 32,98 EUR |
| Min | 32,50 EUR |
| Závěrečná cena (předchozí den) | 31,65 EUR |
| Cena vážená obchodovaným objemem | 32,895 EUR |
| Objem (kusy) | 319 |
| Obchodovaný objem | 10.493,53 |
| Počet obchodů | 11 |
| Poslední zobchodovaný počet | 0 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | -9,35% | -21,36% | -52,77% |
| Výkonn. (abs.) | -3,37 | -8,87 | -36,47 |
| Beta | 0,45 | 0,57 | 0,57 |
| Volatilita | 23,70 | 26,17 | 27,89 |
Přidat benchmark:
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 32,070 EUR (64) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 31,319 EUR (12) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 34,861 EUR (10) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 35,307 EUR (7) |
| YTD Max| datum | 40,625 EUR (02.04.2024) |
| YTD Min | datum | 30,385 EUR (05.07.2024) |
| 52týdenní max. | datum | 44,350 EUR (21.07.2023) |
| 52týdenní min. | datum | 30,050 EUR (16.10.2023) |
Logo společnosti
Kontakty
| BAXTER INTERNATIONAL INC. |
| - - |
| One Baxter Parkway - 60015-4625 Deerfield |
| Telefon:+1-224-948-2000 |
| Fax:+ |
| E-mail:media@baxter.com |
PDF ke stažení
| Report společnosti: BAXTER INTERNATIONAL INC | |
Profil společnosti
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |
Členové představenstva
| D. Shafer | Member of Board of Directors |
| David Wilkes | Member of Board of Directors |
| Stephen Oesterle | Member of Board of Directors |
| Amy McBride-Wendell | Member of Board of Directors |
| Catherine Smith | Member of Board of Directors |
| Cathy Smith | Member of Board of Directors |
| Nancy Schlichting | Member of Board of Directors |
| Patricia Morrison | Member of Board of Directors |
| Peter Wilver | Member of Board of Directors |
| Stephen Rusckowski | Member of Board of Directors |
| William Ampofo | Member of Board of Directors |
| José (Joe) E. Almeida | Chairman of Managing Board |
| Gerard Greco | Member of Executive Committee |
| James W. Borzi | Member of Executive Committee |
| Jeanne Mason | Member of Executive Committee |
| Joel Grade | Member of Executive Committee |
| Talvis Love | Member of Executive Committee |
| Tobi Karchmer | Member of Executive Committee |